Satellite Cell Expression of RAGE (Receptor for Advanced Glycation end Products) Is Important for Collateral Vessel...

Area of Science:

• Vascular Biology
• Regenerative Medicine
• Peripheral Artery Disease Research

Background:

• Vascular network growth and remodeling are critical for peripheral artery disease (PAD) patient outcomes.
• Receptor for advanced glycation end products (RAGE) is implicated in vascular processes.
• The specific cellular source and function of RAGE in ischemic limbs require elucidation.

Purpose of the Study:

• Identify the cellular origin of RAGE in ischemic hind limbs.
• Investigate the role of RAGE signaling within specific cell types in response to ischemia.
• Determine the therapeutic potential of RAGE-expressing cells in promoting vascular repair.

Main Methods:

• Utilized a hind limb ischemia model to study vascular growth.
• Employed staining and cellular sorting to identify RAGE-expressing cells.
• Compared cytokine production and angiogenic function of wild-type versus RAGE-knockout satellite cells in vitro and in vivo.
• Assessed limb perfusion and neovascularization following transplantation of satellite cells.

Main Results:

• Skeletal muscle satellite cells were identified as a novel, major source of RAGE in ischemic tissue.
• Wild-type satellite cells exhibited increased pro-inflammatory cytokine production (TNF-α, MCP-1) upon ischemia or RAGE ligand stimulation, unlike RAGE-knockout cells.
• Transplantation of wild-type satellite cells significantly improved hind limb perfusion and vascularity post-ischemia.
• RAGE-knockout satellite cells failed to enhance perfusion, indicating RAGE-dependent functionality.

Conclusions:

• RAGE expression and signaling within satellite cells are essential for their response to ischemic stimuli.
• Satellite cell-mediated RAGE signaling is crucial for promoting angiogenic and arteriogenic functions.
• Targeting RAGE in satellite cells represents a potential therapeutic strategy for enhancing vascular repair in PAD.